In PC3 prostate cancer cells, MS37452 and MS351 can inhibit CBX7 binding at the INK4A/ARF locus to induce transcriptional de-repression of p16/CDKN2A and inhibit PC3 growth. Here, CBX7 is linked to prostate carcinoma.